EN
HI
Bafna Pharmaceuticals share price chart
Bafna Pharmaceuticals Share Key Metrics
Volume
23659.00
Market Cap
562.31 CR
LTQ@LTP
1@242.45
ATP
236.68
Var Margin
100 %
Circuit Range
232.95-242.45
Delivery %
0 %
Value
56.00 L
ASM/GSM
No
Market Lot
1
Summary
BAFNAPH stock price is ₹242.45 as of 21 Aug, 2026. The stock intraday movement has stayed between ₹232.95 and ₹242.45, while Bafna Pharmaceuticals share price 52 week high low is ₹91.20 & ₹290.70.
In terms of trading activity, BAFNAPH share price has recorded a volume of 23,659 shares. The Bafna Pharmaceuticals has a market cap of ₹23656335. The stock’s Average Traded Price (ATP) stands at ₹236.68, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹242.45.
The Bafna Pharmaceuticals upper circuit limit is ₹242.45 & The Bafna Pharmaceuticals lower circuit limit is ₹232.95, with a Value of ₹56.00 L. The Delivery Percentage for the day is 0%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Bafna Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.06
Sector P/B
3.36
Sec. Div. Yield
0.51
Bafna Pharmaceuticals Resistance and Support
Pivot 237.7
Resistance
First Resistance
237.7
Second Resistance
237.7
Third Resistance
237.7
Support
First Support
237.7
Second Support
237.7
Third Support
237.7
Bafna Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 21 2026 | 242.45 | 242.45 | 2.00% | 242.45 | 232.95 |
| Thu Aug 20 2026 | 237.69 | 237.69 | -2.00% | 237.69 | 237.69 |
| Wed Aug 19 2026 | 242.55 | 242.55 | -2.00% | 242.55 | 242.55 |
Bafna Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Bafna Pharmaceuticals News
Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Intimation for Meeting Scheduled On August 11, 2026
Bafna Pharmaceuticals' Board of Directors will hold a meeting on August 11, 2026. The primary agenda is to consider and approve the un-audited financial results for the first quarter ended June 30, 2026.
Aug 05 2026 17:01:09
Bafna Pharmaceuticals Management
| Name | Position |
|---|---|
| Shanmugam Hemalatha | Whole Time Director |
| Vinayak Dinesh Dendukuri | Whole Time Director - Quality |
Bafna Pharmaceuticals Similar Stocks
Bafna Pharmaceuticals FAQs
The Buying Price of Bafna Pharmaceuticals share is 242.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bafna Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bafna Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bafna Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bafna Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bafna Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.06 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bafna Pharmaceuticals is 562.31 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bafna Pharmaceuticals share price is 290.70 & 91.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bafna Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
